Table 5.
Medical treatment access by age.
| Child (age 0-9.99 years) |
Young adolescent (age 10-15.99) |
Adolescent (age 16+ years) |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Assigned Male
N = 34 |
Assigned Female
N = 15 |
Total
N = 49 |
Assigned Male
N = 33 |
Assigned Female
N = 29 |
Total
N = 62 |
Assigned Male
N = 55 |
Assigned Female
N = 68 |
Total
N = 123 |
|||||||||||
| n | % | n | % | n | % | n | % | N | % | n | % | N | % | n | % | n | % | ||
| Puberty blocking treatment | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 45.5 | 5 | 17.2 | 20 | 32.3 | 24 | 43.6 | 10 | 14.7 | 34 | 27.6 | |
| Menses suppression | n/a | n/a | 0 | 0 | 0 | 0 | n/a | n/a | 16 | 55.2 | n/a | n/a | n/a | n/a | 41 | 60.3 | n/a | n/a | |
| Anti-androgens | 0 | 0 | n/a | n/a | 0 | 0 | 2 | 6.1 | n/a | n/a | n/a | n/a | 5 | 9.1 | n/a | n/a | n/a | n/a | |
| Gender affirming hormones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3.5 | 1 | 1.6 | 19 | 34.6 | 28 | 41.2 | 47 | 38.2 | |
Note. Interventions are not mutually exclusive, therefore individuals who received more than one intervention were counted more than once across the intervention categories. Age calculated as at 31/12/16.